Prenetics Global Limited (PRENW)
USD 0.01
(-2.0%)
USD 0.01
(-2.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -43.33 Million USD | 69.05% |
| 2022 | -140.01 Million USD | -366.38% |
| 2021 | -30.02 Million USD | -134.18% |
| 2020 | -12.82 Million USD | -20.69% |
| 2019 | -10.62 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -40.02 Million USD | 26.4% |
| 2024 Q1 | -52.76 Million USD | -21.77% |
| 2023 Q3 | -49.99 Million USD | 70.79% |
| 2023 FY | -43.33 Million USD | 69.05% |
| 2023 Q4 | -43.33 Million USD | 13.32% |
| 2023 Q2 | -171.14 Million USD | -7.01% |
| 2023 Q1 | -159.92 Million USD | -14.22% |
| 2022 Q2 | -120.23 Million USD | -590.02% |
| 2022 Q1 | -17.42 Million USD | 41.96% |
| 2022 Q4 | -140.01 Million USD | -7.21% |
| 2022 FY | -140.01 Million USD | -366.38% |
| 2022 Q3 | -130.59 Million USD | -8.62% |
| 2021 FY | -30.02 Million USD | -134.18% |
| 2021 Q1 | 18.89 Million USD | 955.64% |
| 2021 Q3 | 434.03 Million USD | 96517.69% |
| 2021 Q4 | -30.02 Million USD | -106.92% |
| 2021 Q2 | -450.16 Thousand USD | -102.38% |
| 2020 Q4 | 1.78 Million USD | 0.0% |
| 2020 FY | -12.82 Million USD | -20.69% |
| 2019 FY | -10.62 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -39.45 Million USD | -9.848% |
| Applied DNA Sciences, Inc. | -5.91 Million USD | -632.783% |
| Aspira Women's Health Inc. | -331 Thousand USD | -12992.767% |
| Biodesix, Inc. | 34.3 Million USD | 226.321% |
| BioNexus Gene Lab Corp. | -5.79 Million USD | -647.714% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | -3386.683% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | -3386.683% |
| Bionano Genomics, Inc. | 34.88 Million USD | 224.239% |
| CareDx, Inc | -47.97 Million USD | 9.669% |
| Check-Cap Ltd. | -24.75 Million USD | -75.057% |
| Castle Biosciences, Inc. | -83.53 Million USD | 48.119% |
| DarioHealth Corp. | -7.54 Million USD | -474.153% |
| Exact Sciences Corporation | 1.94 Billion USD | 102.223% |
| Fulgent Genetics, Inc. | -82.56 Million USD | 47.512% |
| Guardant Health, Inc. | 220.22 Million USD | 119.678% |
| ICON Public Limited Company | 3.56 Billion USD | 101.217% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | 108.774% |
| Illumina, Inc. | 1.21 Billion USD | 103.57% |
| Intelligent Bio Solutions Inc. | -5.43 Million USD | -697.714% |
| iSpecimen Inc. | -2.14 Million USD | -1918.097% |
| Standard BioTools Inc. | 46.5 Million USD | 193.186% |
| MDxHealth SA | 18.88 Million USD | 329.479% |
| 23andMe Holding Co. | -141.37 Million USD | 69.345% |
| Medpace Holdings, Inc. | -103.32 Million USD | 58.058% |
| Myriad Genetics, Inc. | 88.1 Million USD | 149.191% |
| Mainz Biomed B.V. | 349.85 Thousand USD | 12487.149% |
| ENDRA Life Sciences Inc. | -2.43 Million USD | -1676.47% |
| NeoGenomics, Inc. | 269.19 Million USD | 116.099% |
| Neogen Corporation | 735.62 Million USD | 105.891% |
| Inotiv, Inc. | 382.14 Million USD | 111.34% |
| Natera, Inc. | -200.1 Million USD | 78.343% |
| OpGen, Inc. | 11.89 Million USD | 464.426% |
| OPKO Health, Inc. | 230.68 Million USD | 118.786% |
| Psychemedics Corporation | 334 Thousand USD | 13075.168% |
| Prenetics Global Limited | -43.33 Million USD | -0.0% |
| Precipio, Inc. | -386 Thousand USD | -11127.218% |
| Personalis, Inc. | -8.02 Million USD | -440.228% |
| RadNet, Inc. | 1.14 Billion USD | 103.773% |
| Sera Prognostics, Inc. | -2.02 Million USD | -2043.277% |
| Sotera Health Company | 2.02 Billion USD | 102.14% |
| Neuronetics, Inc. | 2.79 Million USD | 1649.412% |
| Star Equity Holdings, Inc. | -15.33 Million USD | -182.565% |
| Star Equity Holdings, Inc. | -15.33 Million USD | -182.565% |
| Trinity Biotech plc | 63.73 Million USD | 167.995% |
| T2 Biosystems, Inc. | 33.8 Million USD | 228.182% |
| Twist Bioscience Corporation | -192.4 Million USD | 77.476% |
| Exagen Inc. | -12.77 Million USD | -239.313% |